Closing Bell: Fennec Pharmaceuticals Inc up on Wednesday (FRX)

In market activity today, Fennec Pharmaceuticals Inc shares closed at $8.89 after opening the day at $8.84. prices ranged from $8.84 to $9.04.

Share prices gained 1.02 percent from the previous day's close of $8.80.

During the day across North America, the TSX Composite closed 1.25% at 23110.81, the S&P 500 closed -0.50% at 5436.44, the Dow Jones Industrial Average closed 0.50% at 40743.33 and the Nasdaq Composite closed -1.28% at 17147.42.

Fennec Pharmaceuticals Inc traded under FRX on the Toronto Stock Exchange (TSX).

A total of 517 shares was traded during the last trading day, with total trades of 6, while having an average volume of 432 in the last five days.

The TSX overall saw 3,418 price advancers against 1,773 declines and 138 unchanged.

During the prior 52 weeks, FRX.TO has traded as high as $15.43 (December 28,2023) and low as $7.80 (July 05,2024). Moreover, the shares have shrunken -21.12 percent in the last year, while they have shrunken -41.36% this year.

Following today's trading, Fennec Pharmaceuticals Inc has a market capitalization of $240.43 million on a float of 27,322 shares outstanding. Its annual EPS is $0.04.

Fennec Pharmaceuticals Inc is a TSX Biotechnology company headquartered in Research Triangle Park, USA.

Currently, Fennec Pharmaceuticals Inc has an average recommendation of "Strong Buy" based on 6.00 analysts according to Zacks. From those 6 analysts, 6 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..